Illinois Tool Works
ITW
261.15
-5.99
-2.24%
Illinois Tool Works
US · ITW
#302 by market cap
Listed 1973
261.15
-5.99
-2.24%
Live - 5344 symbols - heartbeat 81s ago
· 2026-10-08 05:20
Pre-market
261.06
-0.03%
After-hours
261.15
0.00%
Overnight
261.82
+0.26%
- Market cap
- 74.38B
- P/E (TTM)i
- 23.65
- P/Bi
- 25.70
- EPSi
- 10.49
- Div yieldi
- 2.47%
- 52W posi
- 42%
Reader sentiment
Are you bullish or bearish on ITW?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 8.00, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +0.92% YoY
Margins
- Gross margin
- 44.10%
- Operating margin
- 26.28%
- Net margin
- 19.11%
Key ratios & quality
- Enterprise valuei
- 82.56B
- PEG ratioi
- 67.52
- Altman Z-Scorei
- 8.00
PEG uses trailing P/E against the 3-year net income growth rate (0.35%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 14.77B | 14.11B | 12.57B | 14.46B | 15.93B | 16.11B | 15.90B | 16.04B |
| Gross profit | 6.16B | 5.92B | 5.20B | 5.97B | 6.50B | 6.79B | 7.04B | 7.08B |
| Selling & admin expenses | 2.39B | 2.36B | 2.16B | 2.36B | 2.58B | 2.64B | 2.68B | 2.78B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 3.58B | 3.40B | 2.88B | 3.48B | 3.79B | 4.04B | 4.26B | 4.22B |
| Pretax profit | 3.39B | 3.29B | 2.70B | 3.33B | 3.84B | 3.82B | 4.42B | 3.97B |
| Tax | 831.00M | 767.00M | 595.00M | 632.00M | 808.00M | 866.00M | 934.00M | 900.00M |
| Net profit | 2.56B | 2.52B | 2.11B | 2.69B | 3.03B | 2.96B | 3.49B | 3.07B |
| Basic EPS | 8 | 8 | 7 | 9 | 10 | 10 | 12 | 11 |
| Diluted EPS | 7.60 | 7.74 | 6.63 | 8.51 | 9.77 | 9.74 | 11.71 | 10.49 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 3.84B | 4.05B | 4.06B | 4.09B | 4.02B | 4.30B |
| Gross profit | 1.68B | 1.78B | 1.81B | 1.81B | 1.76B | 1.90B |
| Selling & admin expenses | 706.00M | 693.00M | 676.00M | 704.00M | 722.00M | 735.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 951.00M | 1.07B | 1.11B | 1.09B | 1.02B | 1.15B |
| Pretax profit | 895.00M | 998.00M | 1.05B | 1.02B | 967.00M | 1.08B |
| Tax | 195.00M | 243.00M | 228.00M | 234.00M | 199.00M | 265.00M |
| Net profit | 700.00M | 755.00M | 821.00M | 790.00M | 768.00M | 815.00M |
| Basic EPS | 2 | 3 | 3 | 3 | 3 | 3 |
| Diluted EPS | 2.38 | 2.58 | 2.81 | 2.72 | 2.66 | 2.84 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 5.78B | 6.25B | 6.52B | 6.37B | 6.27B | 6.24B | 5.86B | 6.20B |
| Cash & ST investments | 1.50B | 1.98B | 2.56B | 1.53B | 708.00M | 1.07B | 948.00M | 851.00M |
| Inventory | 1.32B | 1.16B | 1.19B | 1.69B | 2.05B | 1.71B | 1.61B | 1.66B |
| Total assets | 14.87B | 15.07B | 15.61B | 16.08B | 15.42B | 15.52B | 15.07B | 16.15B |
| Total current liabilities | 3.54B | 2.15B | 2.59B | 3.47B | 4.46B | 4.68B | 4.31B | 5.13B |
| Short-term debt | 1.35B | 55.00M | 405.00M | 839.00M | 1.65B | 1.88B | 1.61B | 2.35B |
| Long-term debt | 6.03B | 7.75B | 7.77B | 6.91B | 6.17B | 6.34B | 6.31B | 6.68B |
| Total liabilities | 11,612,000,000.00 | 12,038,000,000.00 | 12,430,000,000.00 | 12,451,000,000.00 | 12,333,000,000.00 | 12,505,000,000.00 | 11,750,000,000.00 | 12,922,000,000.00 |
| Total equity | 3.26B | 3.03B | 3.18B | 3.63B | 3.09B | 3.01B | 3.32B | 3.23B |
| Retained earnings | 21.22B | 22.40B | 23.11B | 24.33B | 25.80B | 27.12B | 28.89B | 30.15B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 6.04B | 6.23B | 6.32B | 6.20B | 6.34B | 6.60B |
| Cash & ST investments | 873.00M | 788.00M | 924.00M | 851.00M | 827.00M | 839.00M |
| Inventory | 1.66B | 1.71B | 1.73B | 1.66B | 1.73B | 1.76B |
| Total assets | 15.47B | 16.05B | 16.14B | 16.15B | 16.26B | 16.49B |
| Total current liabilities | 3.78B | 3.93B | 4.13B | 5.13B | 5.33B | 5.95B |
| Short-term debt | 981.00M | 1.24B | 1.27B | 2.35B | 2.55B | 3.15B |
| Long-term debt | 7.28B | 7.70B | 7.68B | 6.68B | 6.60B | 6.55B |
| Total liabilities | 12,226,000,000.00 | 12,837,000,000.00 | 12,926,000,000.00 | 12,922,000,000.00 | 13,034,000,000.00 | 13,599,000,000.00 |
| Total equity | 3.24B | 3.21B | 3.21B | 3.23B | 3.23B | 2.90B |
| Retained earnings | 29.15B | 29.47B | 29.83B | 30.15B | 30.45B | 30.81B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.81B | 3.00B | 2.81B | 2.56B | 2.35B | 3.54B | 3.28B | 3.13B |
| Depreciation & amortization | 461.00M | 426.00M | 427.00M | 410.00M | 410.00M | 395.00M | 402.00M | 397.00M |
| Free cash flow | 2.45B | 2.67B | 2.57B | 2.26B | 1.94B | 3.08B | 2.84B | 2.71B |
| Dividends paid | -1.12B | -1.32B | -1.38B | -1.46B | -1.54B | -1.62B | -1.70B | -1.79B |
| Stock buybacks / issuance | -1.98B | -1.42B | -640.00M | -950.00M | -1.72B | -1.45B | -1.45B | -1.44B |
| Ending cash balance | 1.50B | 1.98B | 2.56B | 1.53B | 708.00M | 1.07B | 948.00M | 851.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 592.00M | 550.00M | 1.02B | 963.00M | 623.00M | 723.00M |
| Depreciation & amortization | 95.00M | 99.00M | 100.00M | 103.00M | 99.00M | 98.00M |
| Free cash flow | 496.00M | 449.00M | 904.00M | 858.00M | 528.00M | 631.00M |
| Dividends paid | -441.00M | -439.00M | -438.00M | -467.00M | -465.00M | -463.00M |
| Stock buybacks / issuance | -331.00M | -372.00M | -362.00M | -370.00M | -323.00M | -750.00M |
| Ending cash balance | 873.00M | 788.00M | 924.00M | 851.00M | 827.00M | 839.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 65.39 | 80.29 | 67.96 | 79.17 | 90.39 | 96.95 | 110.24 | 93.75 |
| ROA %i | 16.20 | 16.84 | 13.75 | 17.00 | 19.26 | 19.11 | 22.81 | 19.64 |
| ROIC %i | 23.19 | 24.71 | 20.10 | 24.77 | 28.19 | 27.86 | 32.28 | 27.37 |
| 5-year avg ROE %i | 42.74 | 51.67 | 58.95 | 66.19 | 76.64 | 82.95 | 88.94 | 94.10 |
| EBIT margin %i | 24.72 | 24.87 | 23.14 | 24.41 | 25.39 | 25.39 | 29.59 | 26.54 |
| FCF / sales %i | 16.57 | 18.92 | 20.45 | 15.64 | 12.15 | 19.15 | 17.89 | 16.87 |
| Current ratioi | 1.63 | 2.90 | 2.52 | 1.84 | 1.41 | 1.33 | 1.36 | 1.21 |
| Quick ratioi | 1.21 | 2.13 | 2.00 | 1.29 | 0.89 | 0.92 | 0.94 | 0.83 |
| Debt / assetsi | 49.63 | 52.67 | 53.23 | 49.02 | 51.54 | 53.94 | 53.61 | 57.04 |
| LT debt / equityi | 185.28 | 260.48 | 248.51 | 194.26 | 204.15 | 215.37 | 194.99 | 212.81 |
| Interest coveragei | 14.21 | 15.88 | 14.13 | 17.47 | 19.93 | 15.37 | 16.63 | 14.58 |
| Revenue CAGR (3Y) %i | 3.28 | 1.23 | -4.23 | -0.71 | 4.13 | 8.60 | 3.22 | 0.23 |
| Net income CAGR (3Y) %i | 10.51 | 7.40 | 7.73 | 1.68 | 6.37 | 11.92 | 8.99 | 0.35 |
| FCF CAGR (3Y) %i | 6.69 | 9.57 | 6.89 | -2.60 | -10.15 | 6.25 | 7.95 | 11.82 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 107.62 | 109.06 | 91.71 | 93.75 | 96.88 | 104.65 |
| ROA %i | 21.65 | 21.28 | 18.94 | 19.64 | 19.75 | 19.63 |
| ROIC %i | 31.43 | 30.42 | 27.18 | 27.37 | 28.18 | 27.72 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 28.70 | 28.61 | 26.51 | 26.54 | 26.72 | 26.85 |
| FCF / sales %i | 18.05 | 17.25 | 17.91 | 16.87 | 16.89 | 17.74 |
| Current ratioi | 1.60 | 1.59 | 1.53 | 1.21 | 1.19 | 1.11 |
| Quick ratioi | 1.07 | 1.04 | 1.01 | 0.83 | 0.79 | 0.74 |
| Debt / assetsi | 53.42 | 55.69 | 55.42 | 57.04 | 56.25 | 58.77 |
| LT debt / equityi | 224.68 | 239.72 | 239.25 | 212.81 | 204.49 | 226.30 |
| Interest coveragei | 16.16 | 16.19 | 14.77 | 14.58 | 14.60 | 14.64 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Automotive Original Equipment Manufacturer (OEM) is the largest reported line at 19.93% of revenue, across 8 reported segments.
- No single line clears half of revenue; Test & Measurement and Electronics is next at 17.88%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Automotive Original Equipment Manufacturer (OEM)19.93%
Test & Measurement and Electronics17.88%
Food Equipment16.09%
Welding12.76%
Construction Products11.49%
Polymers & Fluids11.07%
Specialty products10.88%
Quote time 2026-10-08 05:20:20 · For reference only, not investment advice and not tailored to your situation.